Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Asset disposition
Inv. presentation
Acq. announced
|
|
OPKO HEALTH, INC. (OPK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
8-K
| Quarterly results |
| 08/18/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Bought 1,500 shares
@ $1.735, valued at
$2.6k
Bought 1,450 shares
@ $1.745, valued at
$2.5k
Bought 47,050 shares
@ $1.75, valued at
$82.3k
Bought 3,918 shares
@ $1.755, valued at
$6.9k
Bought 1,850 shares
@ $1.7575, valued at
$3.3k
Bought 23,264 shares
@ $1.76, valued at
$40.9k
Bought 6,168 shares
@ $1.77, valued at
$10.9k
Bought 14,800 shares
@ $1.78, valued at
$26.3k
|
|
| 08/15/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Bought 9,819 shares
@ $1.745, valued at
$17.1k
Bought 57,358 shares
@ $1.75, valued at
$100.4k
Bought 3,900 shares
@ $1.755, valued at
$6.8k
Bought 3,923 shares
@ $1.76, valued at
$6.9k
|
|
| 08/10/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Bought 5,405 shares
@ $1.805, valued at
$9.8k
Bought 20,843 shares
@ $1.81, valued at
$37.7k
Bought 25,752 shares
@ $1.815, valued at
$46.7k
Bought 27,800 shares
@ $1.82, valued at
$50.6k
Bought 6,389 shares
@ $1.825, valued at
$11.7k
Bought 13,811 shares
@ $1.83, valued at
$25.3k
|
|
| 08/08/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Bought 100 shares
@ $1.815, valued at
$181.5
Bought 43,885 shares
@ $1.82, valued at
$79.9k
Bought 3,400 shares
@ $1.8225, valued at
$6.2k
Bought 54,271 shares
@ $1.825, valued at
$99k
Bought 4,530 shares
@ $1.829, valued at
$8.3k
Bought 177,580 shares
@ $1.83, valued at
$325k
Bought 500 shares
@ $1.8325, valued at
$916.3
Bought 33,564 shares
@ $1.835, valued at
$61.6k
Bought 70,000 shares
@ $1.84, valued at
$128.8k
Bought 100 shares
@ $1.8425, valued at
$184.3
Bought 45,527 shares
@ $1.845, valued at
$84k
|
|
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 06/30/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 05/19/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Granted 800,000 options to buy
@ $1.58, valued at
$1.3M
|
|
| 05/19/2023 |
4
| HSIAO JANE PH D (Vice Chairman & CTO) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Granted 800,000 options to buy
@ $1.58, valued at
$1.3M
|
|
| 05/19/2023 |
4
| Zerhouni Elias A. (Vice Chairman and President) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Granted 800,000 options to buy
@ $1.58, valued at
$1.3M
|
|
| 05/19/2023 |
4
| Rubin Steven D (Executive VP-Administration) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Granted 700,000 options to buy
@ $1.58, valued at
$1.1M
|
|
| 05/19/2023 |
4
| Logal Adam (Sr. Vice President, CFO) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Granted 700,000 options to buy
@ $1.58, valued at
$1.1M
|
|
| 05/19/2023 |
4
| Nabel Gary J. (Chief Innovation Officer) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Granted 700,000 options to buy
@ $1.58, valued at
$1.1M
|
|
| 05/19/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/17/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/15/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/08/2023 |
4
| Nabel Gary J. (Chief Innovation Officer) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Bought 19,285 shares
@ $1.78, valued at
$34.3k
Bought 3,185 shares
@ $1.793, valued at
$5.7k
Bought 27,777 shares
@ $1.8, valued at
$50k
Bought 27,624 shares
@ $1.81, valued at
$50k
Bought 79,334 shares
@ $1.82, valued at
$144.4k
Bought 19,475 shares
@ $1.829, valued at
$35.6k
Bought 10,928 shares
@ $1.83, valued at
$20k
Bought 28,538 shares
@ $1.82, valued at
$51.9k
Bought 26,407 shares
@ $1.85, valued at
$48.9k
Bought 54,945 shares
@ $1.82, valued at
$100k
Bought 34,338 shares
@ $1.838, valued at
$63.1k
|
|
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Bought 700 shares
@ $1.31, valued at
$917
Bought 57,100 shares
@ $1.315, valued at
$75.1k
Bought 25,200 shares
@ $1.32, valued at
$33.3k
Bought 116,648 shares
@ $1.325, valued at
$154.6k
Bought 352 shares
@ $1.33, valued at
$468.2 |
|
| 03/09/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Bought 300 shares
@ $1.12, valued at
$336
Bought 39,028 shares
@ $1.125, valued at
$43.9k
Bought 22,049 shares
@ $1.13, valued at
$24.9k
Bought 5,700 shares
@ $1.1325, valued at
$6.5k
Bought 107,200 shares
@ $1.135, valued at
$121.7k
Bought 348,101 shares
@ $1.14, valued at
$396.8k
Bought 13,569 shares
@ $1.145, valued at
$15.5k
Bought 1,900 shares
@ $1.1475, valued at
$2.2k
Bought 81,336 shares
@ $1.15, valued at
$93.5k
Bought 1,000 shares
@ $1.1525, valued at
$1.2k
Bought 59,117 shares
@ $1.155, valued at
$68.3k
|
|
| 03/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/23/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/14/2023 |
4
| FROST PHILLIP MD ET AL (CEO & Chairman) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Disposed/sold convertible notes
@ $5, valued at
$0
Granted convertible notes
@ $1.66, valued at
$0 |
|
| 02/14/2023 |
4
| HSIAO JANE PH D (Vice Chairman & CTO) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Disposed/sold convertible notes
@ $5, valued at
$0
Granted convertible notes
@ $1.66, valued at
$0 |
|
| 02/10/2023 |
8-K
| Quarterly results |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.3% stake in OPKO Health Inc. |
| 02/03/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|